 | • レポートコード：MRC2303J0068 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、231ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、世界の透析装置市場規模が2021年に107.7億ドル、2022年には113.5億ドルに到達し、今後CAGR 5.56％で成長して2027年までに149.0億ドルまで拡大すると予測しています。当調査資料では、透析装置の世界市場について調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別（高フラックス透析装置、低フラックス透析装置、タンパク質漏出膜透析装置）分析、膜素材別（酢酸セルロース膜透析装置、再生セルロース膜透析装置、交換繊維膜透析装置、合成繊維膜透析装置）分析、構成別（フラットタイプ、中空糸タイプ、チューブタイプ）分析、エンドユーザー別（在宅透析、施設内透析）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目をまとめております。なお、当書に掲載されている企業情報には、Allmed Medical Care Holdings Limited、Asahi Kasei Corporation、B. Braun Melsungen AG、Bain Medical Equipment (Guangzhou) Co., Ltd、Baxter International, Inc.、Browndove Healthcare Pvt. Ltd.、Cantel Medical Corporation、Dialife SAなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の透析装置市場規模：種類別 - 高フラックス透析装置の市場規模 - 低フラックス透析装置の市場規模 - タンパク質漏出膜透析装置の市場規模 ・世界の透析装置市場規模：膜素材別 - 酢酸セルロース膜透析装置の市場規模 - 再生セルロース膜透析装置の市場規模 - 交換繊維膜透析装置の市場規模 - 合成繊維膜透析装置の市場規模 ・世界の透析装置市場規模：構成別 - フラットタイプの市場規模 - 中空糸タイプの市場規模 - チューブタイプの市場規模 ・世界の透析装置市場規模：エンドユーザー別 - 在宅透析における市場規模 - 施設内透析における市場規模 ・世界の透析装置市場規模：地域別 - 南北アメリカの透析装置市場規模 アメリカの透析装置市場規模 カナダの透析装置市場規模 ブラジルの透析装置市場規模 ... - アジア太平洋の透析装置市場規模 日本の透析装置市場規模 中国の透析装置市場規模 インドの透析装置市場規模 韓国の透析装置市場規模 台湾の透析装置市場規模 ... - ヨーロッパ/中東/アフリカの透析装置市場規模 イギリスの透析装置市場規模 ドイツの透析装置市場規模 フランスの透析装置市場規模 ロシアの透析装置市場規模 ... - その他地域の透析装置市場規模 ・競争状況 ・企業情報 |
The Global Dialyzer Market size was estimated at USD 10.77 billion in 2021 and expected to reach USD 11.35 billion in 2022, and is projected to grow at a CAGR 5.56% to reach USD 14.90 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Dialyzer to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across High-flux Dialyzer, Low-flux Dialyzer, and Protein-leaking Membrane Dialyzers.
Based on Membrane Material, the market was studied across Acetate Cellulose Membrane Dialyzer, Regenerated Cellulose Membrane Dialyzer, Replace Fiber Membrane Dialyzer, and Synthetic Fiber Membrane Dialyzer.
Based on Ultrafiltration Coefficient, the market was studied across High-throughput & high-efficiency Dialyzer and Low Ultrafiltration Coefficient Dialyzer.
Based on Configuration, the market was studied across Flat Type, Hollow Fiber Type, and Tube Type.
Based on End-User, the market was studied across Home Dialysis and In-center.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Connecticut, Florida, Illinois, Maryland, Minnesota, New Jersey, New York, Ohio, Pennsylvania, Texas, and Washington. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Dialyzer market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Dialyzer Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Dialyzer Market, including Allmed Medical Care Holdings Limited, Asahi Kasei Corporation, B. Braun Melsungen AG, Bain Medical Equipment (Guangzhou) Co., Ltd, Baxter International, Inc., Browndove Healthcare Pvt. Ltd., Cantel Medical Corporation, Dialife SA, Farmasol Medical Products Ind. and Trd. Co., Fresenius Medical Care AG & Co. KGaA, Medica Trading LLC, Medtronic PLC, Nikkiso Co., Ltd., Nipro Corporation, Sb-Kawasumi Laboratories, Inc., Shandong Weigao Group Medical Polymer Company Limited, and Toray Industries, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Dialyzer Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Dialyzer Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Dialyzer Market?
4. What is the competitive strategic window for opportunities in the Global Dialyzer Market?
5. What are the technology trends and regulatory frameworks in the Global Dialyzer Market?
6. What is the market share of the leading vendors in the Global Dialyzer Market?
7. What modes and strategic moves are considered suitable for entering the Global Dialyzer Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of Diabetes and Hypertension Along with Shortage of Kidneys Transplantation
5.1.1.2. Increasing Geriatric Population Combined with Age-Related Kidney Diseases
5.1.1.3. Growth in Funding for Dialysis Products Improvement & Development
5.1.2. Restraints
5.1.2.1. Complications and Risks Associated with the Procedure of Hemodialysis
5.1.3. Opportunities
5.1.3.1. Growing New Developments and Product Approvals Leading to Better Adoption
5.1.3.2. Rising Preference of In-Home Hemodialysis and Potential in Wearables & Portable Dialysis Devices
5.1.4. Challenges
5.1.4.1. Rising Patient Pool Opting for Alternative Kidney Procedures
5.2. Cumulative Impact of COVID-19
6. Dialyzer Market, by Type
6.1. Introduction
6.2. High-flux Dialyzer
6.3. Low-flux Dialyzer
6.4. Protein-leaking Membrane Dialyzers
7. Dialyzer Market, by Membrane Material
7.1. Introduction
7.2. Acetate Cellulose Membrane Dialyzer
7.3. Regenerated Cellulose Membrane Dialyzer
7.4. Replace Fiber Membrane Dialyzer
7.5. Synthetic Fiber Membrane Dialyzer
8. Dialyzer Market, by Ultrafiltration Coefficient
8.1. Introduction
8.2. High-throughput & high-efficiency Dialyzer
8.3. Low Ultrafiltration Coefficient Dialyzer
9. Dialyzer Market, by Configuration
9.1. Introduction
9.2. Flat Type
9.3. Hollow Fiber Type
9.4. Tube Type
10. Dialyzer Market, by End-User
10.1. Introduction
10.2. Home Dialysis
10.3. In-center
11. Americas Dialyzer Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Dialyzer Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Dialyzer Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Allmed Medical Care Holdings Limited
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Asahi Kasei Corporation
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. B. Braun Melsungen AG
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Bain Medical Equipment (Guangzhou) Co., Ltd
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Baxter International, Inc.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Browndove Healthcare Pvt. Ltd.
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Cantel Medical Corporation
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Dialife SA
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Farmasol Medical Products Ind. and Trd. Co.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Fresenius Medical Care AG & Co. KGaA
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Medica Trading LLC
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Medtronic PLC
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Nikkiso Co., Ltd.
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Nipro Corporation
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Sb-Kawasumi Laboratories, Inc.
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Shandong Weigao Group Medical Polymer Company Limited
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Toray Industries, Inc.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
